热门资讯> 正文
诺维信A/S报告第一季度业绩
2026-05-05 22:16
- Novozymes A/S press release (NVZMF): Q1 Sales amounted to EUR 1.12B, 7% organic sales growth Y/Y.
- Adjusted earnings per share was EUR 0.44.
- 2026 outlook confirmed: Organic sales growth is expected to be in the range of 5-7%.
More on Novozymes A/S
- Novozymes A/S (NVZMY) Q1 2026 Earnings Call Transcript
- Novozymes A/S 2026 Q1 - Results - Earnings Call Presentation
- Novozymes A/S (NVZMY) Shareholder/Analyst Call - Slideshow
- Top and bottom quant-rated materials stocks over $10B: Coeur Mining leads 'Strong Buys'
- Seeking Alpha’s Quant Rating on Novozymes A/S
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。